Navigation Links
Study Confirms Anti-Infective ARIKACE(TM) Effectively Penetrates Mucus and Biofilm, and Kills Pseudomonas, a Bacteria Plaguing Cystic Fibrosis Patients
Date:3/31/2008

hrough nebulization where the small aerosol droplet size (~3.0 mm) facilitates lung distribution. Two Phase II studies are currently being conducted in patients that have CF and Pseudomonas lung infections in Europe and the United States. An abstract on the top line European Phase II data in CF has been accepted for presentation at the 31st European Cystic Fibrosis Conference in Prague in June. ARIKACE has been granted orphan drug status in the United States by the FDA and orphan drug designation in Europe by the European Medicines Agency (EMEA) for the treatment of Pseudomonas infections in patients with CF.

About Transave Inc.

Transave Inc is a biopharmaceutical company focused on the development of innovative, inhaled pharmaceuticals for the site-specific treatment of serious lung diseases. The company's major focus is developing antibiotic therapy delivered via next-generation liposomal technology in areas of high unmet need in respiratory disease. Transave is dedicated to leveraging its advanced liposomal development and commercialization expertise, along with its intellectual property, to bring life extending and enhancing medicines to patients.

For more information about Transave's technology and development programs, visit http://www.transaveinc.com/.


'/>"/>
SOURCE Transave Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Kline Study: Better Brushing Habits Boost European Oral Care Sales
4. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
5. NASA study will help stop stowaways to Mars
6. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
7. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
8. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
9. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
10. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
11. Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... septembre 2014 Mapi, société créée à ... a été depuis 40 ans l,un des ... traditionnelles par des évaluations recentrées sur le ... impacts économiques des traitements. Logo ... A cours d,une récente conférence téléphonique avec ...
(Date:9/18/2014)... group of rare diseases that afflict skeletal growth ... hits at the fetal stage and is caused ... encoding fibroblast growth factor receptor 3 (FGFR3) has ... thanatophoric dysplasia (TD), a skeletal dysplasia that cause ... lethal, and achondroplasia (ACH), which causes stunted growth ...
(Date:9/18/2014)... the course of a day - car, phone, ... the chemical industry to turn raw materials such ... valuable chemicals that are the ingredients of life,s ... who achieved outstanding progress in driving this energy ... light instead of fossil fuels, has won the ...
(Date:9/18/2014)... 18, 2014 September 24 marks ASEA's ... ASEA is the manufacturer of the world's first and ... product, RENU28. , The Mexico City event features ... Botero, and ASEA Field Leader Shawn Catmull from Draper, ... in Atomic/Medical Physics from the University of Utah and ...
Breaking Biology Technology:1974 - 2014 - Mapi fête ses 40 ans 2Researchers use iPS cells to show statin effects on diseased bone 2Researchers use iPS cells to show statin effects on diseased bone 3Using solar energy to turn raw materials into ingredients for every day life 2Announcing the ASEA Mexico Grand Opening Tour Beginning September 18th 2
... Northwestern University have developed a model that will allow them ... around them. The model enables further research that may provide ... of papers are published each year that use the rat ... neural processing. Rats move their whiskers rhythmically against objects to ...
... April 7, 2011 Sangamo BioSciences, Inc. (Nasdaq: ... 6,700,000 shares of its common stock pursuant to an effective ... Inc. is the sole book-running manager in this offering and ... to purchase up to 1,005,000 additional shares. ...
... WORCESTER, Mass. and TORONTO, April 7, 2011  Generex ... that this week there will be presentations of ... the Company,s proprietary buccal insulin spray product, at ... The presentations, entitled "Use of Buccal ...
Cached Biology Technology:New model of whiskers provides insight into sense of touch 2New model of whiskers provides insight into sense of touch 3Sangamo Announces Public Offering of Common Stock 2Sangamo Announces Public Offering of Common Stock 3Generex Oral-lyn™ Data to be Presented at Two International Scientific Symposia 2Generex Oral-lyn™ Data to be Presented at Two International Scientific Symposia 3
(Date:9/18/2014)... Miranda, a small, icy moon of Uranus, is ... in the solar system. Despite its relatively small size, ... resurfacing that resulted in the formation of at least ... called coronae. , These coronae are visible in ... 200 km across. Arden corona, the largest, has ridges ...
(Date:9/18/2014)... many times it,s demonstrated, it,s still hard to ... But by using a signaling system called "quorum ... to suit their population. In short, some bacteria ... act accordingly. , Once the population of quorum-sensing ... innocuous to pathogenic, or from unhelpful to helpful. ...
(Date:9/18/2014)... -- Arizona turned its newborn screening program into a model ... earning it the first-ever Newborn Screening Quality Award from the ... Will Humble, M.P.H., Arizona,s Department of Health Services director, with ... established a policy of full transparency for the length of ... to the lab for analysis, and set a target of ...
Breaking Biology News(10 mins):Miranda: An icy moon deformed by tidal heating 2Miranda: An icy moon deformed by tidal heating 3Miranda: An icy moon deformed by tidal heating 4Miranda: An icy moon deformed by tidal heating 5Miranda: An icy moon deformed by tidal heating 6Miranda: An icy moon deformed by tidal heating 7Researchers study vital 'on/off switches' that control when bacteria turn deadly 2Researchers study vital 'on/off switches' that control when bacteria turn deadly 3March of Dimes honors Arizona with first-ever newborn screening award 2March of Dimes honors Arizona with first-ever newborn screening award 3
... cool movies, link at the end of the press release! ... a way to exercise a little mind control over fruit ... on command by triggering genetic "remote controls" that the scientists ... to a new report in the 8 April issue of ...
... into California's Central Valley in the last week of March ... largest migrations of the species on record, said Arthur Shapiro, ... "This may be the biggest migration of modern times," Shapiro ... of butterflies around Trona, near Death Valley, and in the ...
... For a virus to survive, it must elude the ever ... escape immune detection if it resides in nondividing cells and ... flags for immune cells. If the virus targets one of ... while latent. But some viruses, like the gamma-herpesvirus, infect B ...
Cached Biology News:Remote control flies? Fly behavior controlled by laser light 2Remote control flies? Fly behavior controlled by laser light 3Touching Molecules With Your Bare Hands 2Touching Molecules With Your Bare Hands 3